Side-by-side comparison of AI visibility scores, market position, and capabilities
Payment technology company with $9.2B FY2024 revenue; Issuer Solutions spin-off announced 2024; software-led merchant verticals (Heartland, AdvancedMD); competes with Fiserv, Stripe, Adyen.
Global Payments Inc. is a worldwide provider of payment technology and software solutions, founded in 2001 and headquartered in Atlanta, Georgia, trading on NYSE (GPN). The company generated approximately $9.2 billion in revenues for FY2024 under CEO Cameron Bready, who replaced founder-era CEO Jeff Sloan in 2023. Formed through the 2019 merger with TSYS (Total System Services) in a $21.5 billion deal that doubled the company's scale, Global Payments processes approximately $10 trillion in payments annually across merchant acquiring, issuer processing, and business software verticals. In 2024, the company announced a strategic restructuring: separating its Issuer Solutions business (formerly TSYS card issuer processing) into an independent company and divesting its Gaming solutions segment, sharpening focus on its merchant acquiring and commerce enablement core.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.